Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Langer

Showing results (141-150 of 160) with videos related to

Pageof 16
Sort By:
Clinical Pharmacology and Therapeutics|December 15, 2011
Pgp-mediated interaction between (R)-[11C]verapamil and tariquidar at the human blood-brain barrier: a comparison with rat dataM Bauer, M Zeitlinger, R Karch, et al.
Scientific Reports|November 7, 2019
Proof-of-Concept Study of Drug Brain Permeability Between in Vivo Human Brain and an in Vitro iPSCs-Human Blood-Brain Barrier ModelGwenaëlle Le Roux, Rafika Jarray, Anne-Cécile Guyot, et al.
Nuclear Medicine and Biology|November 1, 2018
Molar activity - The keystone in <sup>11</sup>C-radiochemistry: An explorative study using the gas phase methodVerena Pichler, Thomas Zenz, Cécile Philippe, et al.
Bioorganic & Medicinal Chemistry|March 23, 2011
Radiosynthesis and in vivo evaluation of 1-[18F]fluoroelacridar as a positron emission tomography tracer for P-glycoprotein and breast cancer resistance proteinBernd Dörner, Claudia Kuntner, Jens P Bankstahl, et al.
EJNMMI Research|December 14, 2019
Assessment of brain delivery of a model ABCB1/ABCG2 substrate in patients with non-contrast-enhancing brain tumors with positron emission tomographyBeatrix Wulkersdorfer, Martin Bauer, Rudolf Karch, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 18, 2025
Evaluation of dose linearity in the systemic availability and pharmacokinetics of topically administered diclofenac: A <sup>14</sup>C-microdosing study in healthy volunteersSeverin Mairinger, Mihye Kwon, Martin Bauer, et al.
Clinical Pharmacokinetics|January 8, 2022
Microdosing as a Potential Tool to Enhance Clinical Development of Novel Antibiotics: A Tissue and Plasma PK Feasibility Study with CiprofloxacinZoe Oesterreicher, Sabine Eberl, Beatrix Wulkersdorfer, et al.
Molecular Pharmaceutics|September 6, 2018
Effect of Rifampicin on the Distribution of [<sup>11</sup>C]Erlotinib to the Liver, a Translational PET Study in Humans and in MiceMartin Bauer, Alexander Traxl, Akihiro Matsuda, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 12, 2019
Impact of P-Glycoprotein Function on the Brain Kinetics of the Weak Substrate <sup>11</sup>C-Metoclopramide Assessed with PET Imaging in HumansNicolas Tournier, Martin Bauer, Verena Pichler, et al.
Epilepsia|May 9, 2007
Pharmacoresistance in epilepsy: a pilot PET study with the P-glycoprotein substrate R-[(11)C]verapamilOliver Langer, Martin Bauer, Alexander Hammers, et al.
Pageof 16

Showing results (141-150 of 160) with videos related to

Sort By:
Pageof 16
Clinical Pharmacology and Therapeutics|December 15, 2011
Pgp-mediated interaction between (R)-[11C]verapamil and tariquidar at the human blood-brain barrier: a comparison with rat dataM Bauer, M Zeitlinger, R Karch, et al.
Scientific Reports|November 7, 2019
Proof-of-Concept Study of Drug Brain Permeability Between in Vivo Human Brain and an in Vitro iPSCs-Human Blood-Brain Barrier ModelGwenaëlle Le Roux, Rafika Jarray, Anne-Cécile Guyot, et al.
Nuclear Medicine and Biology|November 1, 2018
Molar activity - The keystone in <sup>11</sup>C-radiochemistry: An explorative study using the gas phase methodVerena Pichler, Thomas Zenz, Cécile Philippe, et al.
Bioorganic & Medicinal Chemistry|March 23, 2011
Radiosynthesis and in vivo evaluation of 1-[18F]fluoroelacridar as a positron emission tomography tracer for P-glycoprotein and breast cancer resistance proteinBernd Dörner, Claudia Kuntner, Jens P Bankstahl, et al.
EJNMMI Research|December 14, 2019
Assessment of brain delivery of a model ABCB1/ABCG2 substrate in patients with non-contrast-enhancing brain tumors with positron emission tomographyBeatrix Wulkersdorfer, Martin Bauer, Rudolf Karch, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 18, 2025
Evaluation of dose linearity in the systemic availability and pharmacokinetics of topically administered diclofenac: A <sup>14</sup>C-microdosing study in healthy volunteersSeverin Mairinger, Mihye Kwon, Martin Bauer, et al.
Clinical Pharmacokinetics|January 8, 2022
Microdosing as a Potential Tool to Enhance Clinical Development of Novel Antibiotics: A Tissue and Plasma PK Feasibility Study with CiprofloxacinZoe Oesterreicher, Sabine Eberl, Beatrix Wulkersdorfer, et al.
Molecular Pharmaceutics|September 6, 2018
Effect of Rifampicin on the Distribution of [<sup>11</sup>C]Erlotinib to the Liver, a Translational PET Study in Humans and in MiceMartin Bauer, Alexander Traxl, Akihiro Matsuda, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 12, 2019
Impact of P-Glycoprotein Function on the Brain Kinetics of the Weak Substrate <sup>11</sup>C-Metoclopramide Assessed with PET Imaging in HumansNicolas Tournier, Martin Bauer, Verena Pichler, et al.
Epilepsia|May 9, 2007
Pharmacoresistance in epilepsy: a pilot PET study with the P-glycoprotein substrate R-[(11)C]verapamilOliver Langer, Martin Bauer, Alexander Hammers, et al.
Pageof 16